943
Views
76
CrossRef citations to date
0
Altmetric
Reviews

Targeted delivery of antibody-based therapeutic and imaging agents to CNS tumors: crossing the blood–brain barrier divide

, , , , &
Pages 907-926 | Published online: 11 Jun 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Hongyu Xu, Lin Zhou, You Lu, Xiaomei Su, Peng Cheng, Dong Li, Hui Gao, Hua Li, Weiwei Yuan, Ling Zhang & Tao Zhang. (2020) Dual Targeting of the Epidermal Growth Factor Receptor Using Combination of Nimotuzumab and Erlotinib in Advanced Non-Small-Cell Lung Cancer with Leptomeningeal Metastases: A Report of Three Cases. OncoTargets and Therapy 13, pages 647-656.
Read now
Mauro Magnani & Luigia Rossi. (2014) Approaches to erythrocyte-mediated drug delivery. Expert Opinion on Drug Delivery 11:5, pages 677-687.
Read now
Eliana B Souto. (2013) Expert Opinion. Expert Opinion on Drug Delivery 10:7, pages i-ii.
Read now

Articles from other publishers (73)

Johid Reza Malik, Anthony T. Podany, Parvez Khan, Christopher L. Shaffer, Jawed A. Siddiqui, Janina Baranowska‐Kortylewicz, Jennifer Le, Courtney V. Fletcher, Sadia Afruz Ether & Sean N. Avedissian. (2023) Chemotherapy in pediatric brain tumor and the challenge of the blood–brain barrier. Cancer Medicine.
Crossref
Rishab Ramapriyan, Jing Sun, Annabel Curry, Leland G. Richardson, Tarun Ramesh, Matthew A. Gaffey, Patrick C. Gedeon, Elizabeth R. Gerstner, William T. Curry & Bryan D. Choi. (2023) The Role of Antibody-Based Therapies in Neuro-Oncology. Antibodies 12:4, pages 74.
Crossref
Oadi N. Shrateh & Shadi Abu Saa. (2023) Very rare metastatic phenomena of biliary tract cancer to the cerebellum: A case report and review of the literature. International Journal of Surgery Case Reports 111, pages 108819.
Crossref
Shabnam Shabir, Amit Sehgal, Joydeep Dutta, Inderpal Devgon, Sandeep K. Singh, Walaa F. Alsanie, Abdulhakeem S. Alamri, Majid Alhomrani, Abdulaziz Alsharif, Mohammed Abubaker Mohammed Basalamah, Hani Faidah, Farkad Bantun, Abdullah Ali Saati, Emanuel Vamanu & Mahendra P. Singh. (2023) Therapeutic Potential of Green-Engineered ZnO Nanoparticles on Rotenone-Exposed D. melanogaster (Oregon R+): Unveiling Ameliorated Biochemical, Cellular, and Behavioral Parameters. Antioxidants 12:9, pages 1679.
Crossref
Seoyeon Won, Jeongyeon An, Hwayoung Song, Subin Im, Geunho You, Seungho Lee, Kyo-in Koo & Chang Ho Hwang. (2023) Transnasal targeted delivery of therapeutics in central nervous system diseases: a narrative review. Frontiers in Neuroscience 17.
Crossref
Amy H. Guadagno & Scott H. Medina. (2023) The manifold role of octapeptide repeats in prion protein assembly. Peptide Science 115:2.
Crossref
Xin Peng, Shaolu Zhang, Yingying Wang, Zhicheng Zhou, Zixiang Yu, Zhenxing Zhong, Liang Zhang, Zhe‐Sheng Chen, Francois X. Claret, Moshe Elkabets, Feng Wang, Fan Sun, Ran Wang, Han Liang, Hou‐Wen Lin & Dexin Kong. (2022) Stellettin B Sensitizes Glioblastoma to DNA‐Damaging Treatments by Suppressing PI3K‐Mediated Homologous Recombination Repair. Advanced Science 10:3.
Crossref
Suzanne Edavettal, Pilar Cejudo-Martin, Bidisha Dasgupta, Danlin Yang, Matthew D. Buschman, Derrick Domingo, Kristof Van Kolen, Pharavee Jaiprasat, Renata Gordon, Keith Schutsky, Brian Geist, Natalie Taylor, Camille Helene Soubrane, Elisabeth Van Der Helm, Ann LaCombe, Zemeda Ainekulu, Eilyn Lacy, Jason Aligo, Jason Ho, Yingbo He, Peter F. Lebowitz, James T. Patterson, Justin M. Scheer & Sanjaya Singh. (2022) Enhanced delivery of antibodies across the blood-brain barrier via TEMs with inherent receptor-mediated phagocytosis. Med 3:12, pages 860-882.e15.
Crossref
Arthur J. Van De Vyver, Antje-Christine Walz, Mariette S. Heins, Afsaneh Abdolzade-Bavil, Thomas E. Kraft, Inja Waldhauer & Michael B. Otteneder. (2022) Investigating brain uptake of a non-targeting monoclonal antibody after intravenous and intracerebroventricular administration. Frontiers in Pharmacology 13.
Crossref
Xihui Gao, Jinliang Xu, Tingting Yao, Xiaoxiao Liu, Hanchang Zhang & Changyou Zhan. (2022) Peptide-decorated nanocarriers penetrating the blood-brain barrier for imaging and therapy of brain diseases. Advanced Drug Delivery Reviews 187, pages 114362.
Crossref
Yu Tang, Zhonghui Liao, Feize Li, Weihao Liu, Jing Gao, Yuhao Li, Yingjiang Hu, Huawei Cai, Huan Ma, Yuanyou Yang, Jijun Yang, Jiali Liao & Ning Liu. (2022) A novel theranostic probe [ 111 In]In-DO3A-NHS-nimotuzumab in glioma xenograft . Radiochimica Acta 110:5, pages 381-392.
Crossref
Aanchal Udaynath Pareri, Arunkumar Singh Koijam & Chandan Kumar. (2022) Breaking the Silence of Tumor Response: Future Prospects of Targeted Radionuclide Therapy. Anti-Cancer Agents in Medicinal Chemistry 22:10, pages 1845-1858.
Crossref
Mengyuan Zhu, Haijian Sun, Lei Cao, Zhiyuan Wu, Bin Leng & Jinsong Bian. (2021) Role of Na+/K+-ATPase in ischemic stroke: in-depth perspectives from physiology to pharmacology. Journal of Molecular Medicine 100:3, pages 395-410.
Crossref
Tao Sun, Qiaoqiao Shi, Yongzhi Zhang, Chanikarn Power, Camilla Hoesch, Shawna Antonelli, Maren K. Schroeder, Barbara J. Caldarone, Nadine Taudte, Mathias Schenk, Thore Hettmann, Stephan Schilling, Nathan J. McDannold & Cynthia A. Lemere. (2021) Focused ultrasound with anti-pGlu3 Aβ enhances efficacy in Alzheimer's disease-like mice via recruitment of peripheral immune cells. Journal of Controlled Release 336, pages 443-456.
Crossref
Aida Kouhi, Vyshnavi Pachipulusu, Talya Kapenstein, Peisheng Hu, Alan L. Epstein & Leslie A. Khawli. (2021) Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and Perspectives. International Journal of Molecular Sciences 22:12, pages 6442.
Crossref
Lichun Wang, Sitong Liu, Jiaqi Xu, Nobumoto Watanabe, Kevin H. Mayo, Jiang Li & Xiaomeng Li. (2020) Emodin inhibits aggregation of amyloid‐β peptide 1–42 and improves cognitive deficits in Alzheimer's disease transgenic mice. Journal of Neurochemistry 157:6, pages 1992-2007.
Crossref
Yu Tang & Yanguang Cao. (2021) Modeling Pharmacokinetics and Pharmacodynamics of Therapeutic Antibodies: Progress, Challenges, and Future Directions. Pharmaceutics 13:3, pages 422.
Crossref
Natasha D. Sheybani, Victoria R. Breza, Soumen Paul, Katelyenn S. McCauley, Stuart S. Berr, G. Wilson Miller, Kiel D. Neumann & Richard J. Price. (2021) ImmunoPET-informed sequence for focused ultrasound-targeted mCD47 blockade controls glioma. Journal of Controlled Release 331, pages 19-29.
Crossref
Roberta Stoica, Călin Mircea Rusu, Cristina Elena Staicu, Andreea Elena Burlacu, Mihai Radu & Beatrice Mihaela Radu. 2021. Inter-Organellar Ca2+ Signaling in Health and Disease - Part A. Inter-Organellar Ca2+ Signaling in Health and Disease - Part A 55 110 .
Sanjay B. Patil. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery 267 285 .
Zeming Chen, Ann T. Chen & Jiangbing Zhou. 2021. Nanotherapy for Brain Tumor Drug Delivery. Nanotherapy for Brain Tumor Drug Delivery 245 257 .
Mei Mei Tian & Reinhard Gabathuler. 2021. Nanomedicines for Brain Drug Delivery. Nanomedicines for Brain Drug Delivery 119 147 .
Vu Long Tran, Anthony Novell, Nicolas Tournier, Matthieu Gerstenmayer, Arnaud Schweitzer-Chaput, Claudia Mateos, Benoit Jego, Alizée Bouleau, Hervé Nozach, Alexandra Winkeler, Bertrand Kuhnast, Benoit Larrat & Charles Truillet. (2020) Impact of blood-brain barrier permeabilization induced by ultrasound associated to microbubbles on the brain delivery and kinetics of cetuximab: An immunoPET study using 89Zr-cetuximab. Journal of Controlled Release 328, pages 304-312.
Crossref
Pierre Mora, Pierre-Louis Hollier, Sarah Guimbal, Alice Abelanet, Aïssata Diop, Lauriane Cornuault, Thierry Couffinhal, Sam Horng, Alain-Pierre Gadeau, Marie-Ange Renault & Candice Chapouly. (2020) Blood–brain barrier genetic disruption leads to protective barrier formation at the Glia Limitans. PLOS Biology 18:11, pages e3000946.
Crossref
Kyoungmin Lee, Harim Koo, Yejin Kim, Donggeon Kim, Eunju Son, Heekyoung Yang, Yangmi Lim, Minkyu Hur, Hye Won Lee, Seung Won Choi & Do-Hyun Nam. (2020) Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts. Cancers 12:11, pages 3210.
Crossref
Michael M. Lübtow, Sabrina Oerter, Sabina Quader, Elisabeth Jeanclos, Alevtina Cubukova, Marion Krafft, Malik Salman Haider, Clemens Schulte, Laura Meier, Maximilian Rist, Oltea Sampetrean, Hiroaki Kinoh, Antje Gohla, Kazunori Kataoka, Antje Appelt-Menzel & Robert Luxenhofer. (2020) In Vitro Blood–Brain Barrier Permeability and Cytotoxicity of an Atorvastatin-Loaded Nanoformulation Against Glioblastoma in 2D and 3D Models . Molecular Pharmaceutics 17:6, pages 1835-1847.
Crossref
Megan R. D'Andrea, Corey M. Gill, Melissa Umphlett, Nadejda M. Tsankova, Mary Fowkes, Joshua B. Bederson, Priscilla K. Brastianos & Raj K. Shrivastava. (2020) Brain Metastases from Biliary Tract Cancers: A Case Series and Review of the Literature in the Genomic Era. The Oncologist 25:5, pages 447-453.
Crossref
Anders W. Erickson, Priscilla K. Brastianos & Sunit Das. (2020) Assessment of Effectiveness and Safety of Osimertinib for Patients With Intracranial Metastatic Disease. JAMA Network Open 3:3, pages e201617.
Crossref
Chinami Masuda, Masamichi Sugimoto, Daiko Wakita, Makoto Monnai, Chisako Ishimaru, Ryo Nakamura, Mari Kinoshita, Keigo Yorozu, Mitsue Kurasawa, Osamu Kondoh & Kaname Yamamoto. (2019) Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model. Clinical & Experimental Metastasis 37:1, pages 199-207.
Crossref
Meng Qin, Lan Wang, Di Wu, Christopher K. Williams, Duo Xu, Emiko Kranz, Qi Guo, Jiaoqiong Guan, Harry V. Vinters, YooJin Lee, Yiming Xie, Yun Luo, Guibo Sun, Xiaobo Sun, Zhanlong He, Yunfeng Lu, Masakazu Kamata, Jing Wen & Irvin S. Y. Chen. (2020) Enhanced Delivery of Rituximab Into Brain and Lymph Nodes Using Timed-Release Nanocapsules in Non-Human Primates. Frontiers in Immunology 10.
Crossref
Franciele Aline Bruinsmann, Gustavo Richter Vaz, Aline de Cristo Soares Alves, Tanira Aguirre, Adriana Raffin Pohlmann, Silvia Stanisçuaski Guterres & Fabio Sonvico. (2019) Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials. Molecules 24:23, pages 4312.
Crossref
Luke D Hughes. (2019) Differential diagnosis for a ring-enhancing lesion on CT/MRI brain: retained cotton ball pledget. Journal of Surgical Case Reports 2019:11.
Crossref
Ulapane, Kopec & Siahaan. (2019) Improving In Vivo Brain Delivery of Monoclonal Antibody Using Novel Cyclic Peptides. Pharmaceutics 11:11, pages 568.
Crossref
Puttemans, Lahoutte, D’Huyvetter & Devoogdt. (2019) Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases. Pharmaceutics 11:8, pages 376.
Crossref
Sara RamezaniNasim VousooghiMohammad Taghi JoghataeiShahrokh Yousefzadeh Chabok. (2019) The Role of Kinase Signaling in Resistance to Bevacizumab Therapy for Glioblastoma Multiforme. Cancer Biotherapy and Radiopharmaceuticals 34:6, pages 345-354.
Crossref
Peng Guo, Alexander Moses-Gardner, Jing Huang, Edward R. Smith & Marsha A. Moses. (2019) ITGA2 as a potential nanotherapeutic target for glioblastoma. Scientific Reports 9:1.
Crossref
Fernanda Pohl-Guimarães, Changlin Yang, Kyle A. Dyson, Tyler J. Wildes, Jeffrey Drake, Jianping Huang, Catherine Flores, Elias J. Sayour & Duane A. Mitchell. (2019) RNA-Modified T Cells Mediate Effective Delivery of Immunomodulatory Cytokines to Brain Tumors. Molecular Therapy 27:4, pages 837-849.
Crossref
Erin E. Congdon, Jessica E. Chukwu, Dov B. Shamir, Jingjing Deng, Devyani Ujla, Hameetha B.R. Sait, Thomas A. Neubert, Xiang-Peng Kong & Einar M. Sigurdsson. (2019) Tau antibody chimerization alters its charge and binding, thereby reducing its cellular uptake and efficacy. EBioMedicine 42, pages 157-173.
Crossref
Raghupathy Vengoji, Moorthy P Ponnusamy, Satyanarayana Rachagani, Sidharth Mahapatra, Surinder K Batra, Nicole Shonka & Muzafar A Macha. (2019) Novel therapies hijack the blood–brain barrier to eradicate glioblastoma cancer stem cells. Carcinogenesis 40:1, pages 2-14.
Crossref
Yu Tang, Yingjiang Hu, Weihao Liu, Lin Chen, Yan Zhao, Huan Ma, Jijun Yang, Yuanyou Yang, Jiali Liao, Jiming Cai, Yue Chen & Ning Liu. (2019) A radiopharmaceutical [89Zr]Zr-DFO-nimotuzumab for immunoPET with epidermal growth factor receptor expression in vivo. Nuclear Medicine and Biology 70, pages 23-31.
Crossref
Fengjin Hao, Yueqin Feng & Yifu Guan. (2019) Light Chain LC and TAT-EGFP-HCS of Botulinum Toxin Expression and Biological Function in vitro and in vivo . Current Proteomics 16:3, pages 175-180.
Crossref
Yasmin Leshem & Ira Pastan. (2019) Pseudomonas Exotoxin Immunotoxins and Anti-Tumor Immunity: From Observations at the Patient’s Bedside to Evaluation in Preclinical Models. Toxins 11:1, pages 20.
Crossref
Rui Pedro Moura, Flávia Sousa, Andreia Almeida, Soraia Pinto & Bruno Sarmento. 2019. Theranostic Bionanomaterials. Theranostic Bionanomaterials 303 319 .
Ronan Flippot, Lisa Derosa & Laurence Albiges. (2018) Les métastases cérébrales de cancer du rein, un défi clinique. Bulletin du Cancer 105, pages S261-S267.
Crossref
Niyanta N. Kumar, Jeffrey J. Lochhead, Michelle E. Pizzo, Geetika Nehra, Sam Boroumand, Gretchen Greene & Robert G. Thorne. (2018) Delivery of immunoglobulin G antibodies to the rat nervous system following intranasal administration: Distribution, dose-response, and mechanisms of delivery. Journal of Controlled Release 286, pages 467-484.
Crossref
Artur Beberok, Zuzanna Rzepka, Michalina Respondek, Jakub Rok, Daniel Sierotowicz & Dorota Wrześniok. (2018) GSH depletion, mitochondrial membrane breakdown, caspase-3/7 activation and DNA fragmentation in U87MG glioblastoma cells: New insight into the mechanism of cytotoxicity induced by fluoroquinolones. European Journal of Pharmacology 835, pages 94-107.
Crossref
Andrea Shergalis, Armand BankheadIIIIII, Urarika Luesakul, Nongnuj Muangsin & Nouri Neamati. (2018) Current Challenges and Opportunities in Treating Glioblastoma. Pharmacological Reviews 70:3, pages 412-445.
Crossref
Divya Khaitan, Polluru L. Reddy, Divya S. Narayana & Nagendra S. Ningaraj. 2018. Drug Targeting and Stimuli Sensitive Drug Delivery Systems. Drug Targeting and Stimuli Sensitive Drug Delivery Systems 673 688 .
Min-Chi Ku, Sonia Waiczies, Thoralf Niendorf & Andreas Pohlmann. 2018. Preclinical MRI. Preclinical MRI 395 408 .
Andrew TL Wotherspoon, Mitra Safavi-Naeini & Richard B Banati. (2017) Microdosing, isotopic labeling, radiotracers and metabolomics: relevance in drug discovery, development and safety. Bioanalysis 9:23, pages 1913-1933.
Crossref
Paul Malik, Colin Phipps, Andrea Edginton & Jonathan Blay. (2017) Pharmacokinetic Considerations for Antibody-Drug Conjugates against Cancer. Pharmaceutical Research 34:12, pages 2579-2595.
Crossref
Mark Owyong, Niloufar Hosseini-Nassab, Gizem Efe, Alexander Honkala, Renske J.E. van den Bijgaart, Vicki Plaks & Bryan Ronain Smith. (2017) Cancer Immunotherapy Getting Brainy: Visualizing the Distinctive CNS Metastatic Niche to Illuminate Therapeutic Resistance. Drug Resistance Updates 33-35, pages 23-35.
Crossref
Rok Razpotnik, Neža Novak, Vladka Čurin Šerbec & Uros Rajcevic. (2017) Targeting Malignant Brain Tumors with Antibodies. Frontiers in Immunology 8.
Crossref
James J. LynchIIIIII, Terry R. Van Vleet, Scott W. Mittelstadt & Eric A.G. Blomme. (2017) Potential functional and pathological side effects related to off-target pharmacological activity. Journal of Pharmacological and Toxicological Methods 87, pages 108-126.
Crossref
Michaela Jung, Christina Mertens, Rebekka Bauer, Claudia Rehwald & Bernhard Brüne. (2017) Lipocalin-2 and iron trafficking in the tumor microenvironment. Pharmacological Research 120, pages 146-156.
Crossref
Talita Glaser, Inbo Han, Liquan Wu & Xiang Zeng. (2017) Targeted Nanotechnology in Glioblastoma Multiforme. Frontiers in Pharmacology 8.
Crossref
Ranjith Ramachandran, Vijayabhaskar Reddy Junnuthula, G. Siddaramana Gowd, Anusha Ashokan, John Thomas, Reshmi Peethambaran, Anoop Thomas, Ayalur Kodakara Kochugovindan Unni, Dilip Panikar, Shantikumar V. Nair & Manzoor Koyakutty. (2017) Theranostic 3-Dimensional nano brain-implant for prolonged and localized treatment of recurrent glioma. Scientific Reports 7:1.
Crossref
Jianing Meng, Vivek Agrahari & Ibrahima Youm. (2016) Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology. Journal of Neuroimmune Pharmacology 12:1, pages 84-98.
Crossref
Umberto Tosi, Christopher Marnell, Raymond Chang, William Cho, Richard Ting, Uday Maachani & Mark Souweidane. (2017) Advances in Molecular Imaging of Locally Delivered Targeted Therapeutics for Central Nervous System Tumors. International Journal of Molecular Sciences 18:2, pages 351.
Crossref
Menghuan Li, Zhong Luo, Zhining Xia, Xinkun Shen & Kaiyong Cai. (2017) Time-sequenced drug delivery approaches towards effective chemotherapeutic treatment of glioma. Materials Horizons 4:6, pages 977-996.
Crossref
Jun Yang, Yan Li, Tianlu Zhang & Xin Zhang. (2016) Development of bioactive materials for glioblastoma therapy. Bioactive Materials 1:1, pages 29-38.
Crossref
Jing-Zhang Wang, Ning Xiao, Ying-Zhou Zhang, Chao-Xian Zhao, Xin-Hua Guo & Li-Min Lu. (2016) Mfsd2a-based pharmacological strategies for drug delivery across the blood–brain barrier. Pharmacological Research 104, pages 124-131.
Crossref
Jean-Michel Escoffre, Roel Deckers, Clemens Bos & Chrit Moonen. 2016. Therapeutic Ultrasound. Therapeutic Ultrasound 243 261 .
Jianfeng Guo, Kamil Rahme, Kathleen A. Fitzgerald, Justin D. Holmes & Caitriona M. O’Driscoll. (2015) Biomimetic gold nanocomplexes for gene knockdown: Will gold deliver dividends for small interfering RNA nanomedicines?. Nano Research 8:10, pages 3111-3140.
Crossref
Synnøve Aasen, Aneta Pospisilova, Tilo Eichler, Jiri Panek, Martin Hruby, Petr Stepanek, Endy Spriet, Daniel Jirak, Kai Skaftnesmo & Frits Thorsen. (2015) A Novel Nanoprobe for Multimodal Imaging Is Effectively Incorporated into Human Melanoma Metastatic Cell Lines. International Journal of Molecular Sciences 16:9, pages 21658-21680.
Crossref
Micah John Luderer, Pilar de la Puente & Abdel Kareem Azab. (2015) Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy. Pharmaceutical Research 32:9, pages 2824-2836.
Crossref
Iason T Papademetriou & Tyrone Porter. (2015) Promising approaches to circumvent the blood–brain barrier: progress, pitfalls and clinical prospects in brain cancer. Therapeutic Delivery 6:8, pages 989-1016.
Crossref
Philip J Santangelo, Kenneth A Rogers, Chiara Zurla, Emmeline L Blanchard, Sanjeev Gumber, Karen Strait, Fawn Connor-Stroud, David M Schuster, Praveen K Amancha, Jung Joo Hong, Siddappa N Byrareddy, James A Hoxie, Brani Vidakovic, Aftab A Ansari, Eric Hunter & Francois Villinger. (2015) Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy–treated macaques. Nature Methods 12:5, pages 427-432.
Crossref
Tej D. Azad, James Pan, Ian D. Connolly, Austin Remington, Christy M. Wilson & Gerald A. Grant. (2015) Therapeutic strategies to improve drug delivery across the blood-brain barrier. Neurosurgical Focus 38:3, pages E9.
Crossref
Rong Wang, Wenli Chen, Qiang Zhang, Yong Liu, Xiaoyun Qiao, Kui Meng & Ying Mao. (2014) Phosphodiesterase type 5 inhibitor Tadalafil increases Rituximab treatment efficacy in a mouse brain lymphoma model. Journal of Neuro-Oncology 122:1, pages 35-42.
Crossref
Matthias J. Feige & Johannes Buchner. (2014) Principles and engineering of antibody folding and assembly. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1844:11, pages 2024-2031.
Crossref
Jie Zhang, Simon J. O'Carroll, Kimiora Henare, Lai-Ming Ching, Susan Ormonde, Louise F.B. Nicholson, Helen V. Danesh-Meyer & Colin R. Green. (2014) Connexin hemichannel induced vascular leak suggests a new paradigm for cancer therapy. FEBS Letters 588:8, pages 1365-1371.
Crossref
John L. MikitshAnn-Marie Chacko. (2014) Pathways for Small Molecule Delivery to the Central Nervous System across the Blood-Brain Barrier. Perspectives in Medicinal Chemistry 6, pages PMC.S13384.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.